GGrantIndex
Sort

50,496 grants matching lung cancer

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

$559,275
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Therapeutic strategies for specific subsets of KRAS mutant lung cancers

$559,228
Kwok Kin Wong · New York University School Of Medicine · R01 · FY2017 · CA

The Role of Fgf Signaling in Vertebrate Development

$559,198
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Interpretable graphical models for large multi-modal COPD data

$559,193
Panagiotis V Benos · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Molecular and Genetic Analysis of Lung Cancer Survival

$559,058
David C Christiani · Harvard School Of Public Health · R01 · FY2012 · CA

The effect of intermittent versus continuous dose aspirin (ASA) on nasal epitheli

$559,042
University Of Arizona · N03 · FY2013 · CA

Web-based Smoking Cessation Program for Tribal College Students

$558,995
Won S Choi · University Of Kansas Medical Center · R01 · FY2014 · CA

Cancer Genetic Markers of Susceptibility

$558,955
Stephen J Chanock · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations

$558,923
Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer

$558,923
Katerina Abigail Politi · Yale University · R01 · FY2023 · CA

Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung CancerÂ

$558,907
James G. Herman · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · CA

A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use

$558,907
Joseph Reginald Osborne · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Oncogenic Met Signaling in Urologic Malignancies

$558,896
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Reducing the Symptom Burden Produced by Aggressive Cancer Therapies

$558,851
Charles S Cleeland · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA

Leveraging canine spontaneous cancer to optimize the power of blood biopsy

$558,828
Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · CA

TARGETED REPOLARIZATION OF TUMOR-ASSOCIATED MACROPHAGES IN LUNG CANCER

$558,674
Trustees Of The University Of Pennsylvania, The · · FY2015 · Department of the Army

Identifying the pro-metastatic mechanisms of neutrophil extracellular traps

$558,667
Mikala Egeblad · Cold Spring Harbor Laboratory · R01 · FY2020 · CA

A Web-Based Smoking Intervention for Cancer Survivors

$558,648
Karen M Emmons · Dana-Farber Cancer Inst · R01 · FY2007 · CA

Elucidating genetics of response to immune checkpoint blockade in lung cancer

$558,644
Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2018 · CA

Elucidating genetics of response to immune checkpoint blockade in lung cancer

$558,644
Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2020 · CA

Radiomics of NSCLC

$558,629
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2011 · CA

Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer

$558,611
Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA

Manipulating normal estrogen physiology as a therapeutic approach in cancer

$558,602
Donald P McDonnell · Duke University · R01 · FY2023 · CA

Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma

$558,404
David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2014 · CA

HER2-mediated delivery of cytotoxic agents in solid tumors

$558,399
Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA